Evidence map›Paper›PMID 29216211›Full record

ArticlePloS one2017

Validation of the Japanese version of the Central Sensitization Inventory in patients with musculoskeletal disorders.

Katsuyoshi Tanaka, Tomohiko Nishigami, Akira Mibu, Masahiro Manfuku, Satoko Yono, Yoshikazu Shinohara, Akihito Tanabe, Rei Ono

Open access · goldAbstract readValidation Study
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed, 1 pooled it
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 1 synthesis or guideline pooled it, 133 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Katsuyoshi TanakaDepartment of Rehabilitation, Tanabe Orthopaedics, Osaka, Osaka, Japan.
Tomohiko NishigamiDepartment of Nursing and Physical Therapy, Konan Women's University, Kobe, Hyogo, Japan.ORCID http://orcid.org/0000-0002-6969-8916
Akira MibuDepartment of Rehabilitation, Tanabe Orthopaedics, Osaka, Osaka, Japan.
Masahiro ManfukuDepartment of Rehabilitation, Tanabe Orthopaedics, Osaka, Osaka, Japan.
Satoko YonoDepartment of Rehabilitation, Tanabe Orthopaedics, Osaka, Osaka, Japan.
Yoshikazu ShinoharaDepartment of Rehabilitation, Tanabe Orthopaedics, Osaka, Osaka, Japan.
Akihito TanabeDepartment of Rehabilitation, Tanabe Orthopaedics, Osaka, Osaka, Japan.
Rei OnoDepartment of Community Health Sciences, Kobe University Graduate School of Health Sciences, Kobe, Hyogo, Japan.
Hyogo University of Health Sciences · JPKonan Women's University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMany musculoskeletal pain conditions are characterized by hypersensitivity, which is induced by central sensitization (CS). A questionnaire, the Central Sensitization Inventory (CSI), was recently developed to help clinicians identify patients whose presenting symptoms may be related to central sensitivity syndrome (CSS). The aims of the present study were to examine criterion validity and construct validity of the Japanese version of the CSI (CSI-J), and to investigate prevalence rates of CS severity levels in patients with musculoskeletal disorders.

methodsTranslation of the CSI into Japanese was conducted using a forward-backward method. Two hundred and ninety patients with musculoskeletal pain disorders completed the resultant CSI-J. A subset of the patients (n = 158) completed the CSI-J again one week later. The relationships between CSI and clinical symptoms, EuroQol 5-dimension (EQ-5D) and Brief Pain Inventory (BPI), were examined for criterion validity. EQ-5D assesses Health-related QOL and BPI measures pain intensity and pain interference. The psychometric properties were evaluated with analyses of construct validity, factor structure and internal consistency, and subsequently investigate the prevalence rates of CS severity levels.

resultsThe CSI-J demonstrated high internal consistency (Cronbach's α = 0.89) and test-retest reliability was excellent value (ICC = 0.85). The CSI-J was significantly correlated with EQ-5D (r = -0.44), pain intensity (r = 0.42), and pain interference (r = 0.48) (p < 0.01 for all). Ten percent of the participants were above the cutoff "40". The exploratory factor analysis resulted in 5-factor model.

conclusionsThis study reported that the CSI-J was a useful and psychometrically sound tool to assess CSS in Japanese patients with musculoskeletal disorders. The finding of the prevalence rates of CS severity levels in patients with musculoskeletal disorders may help clinicians to decide strategy of treatment.

Indexed as

Central Nervous System SensitizationAdultFemaleHumansJapanMaleMiddle AgedMusculoskeletal DiseasesSeverity of Illness IndexSurveys and Questionnaires

Identifiers

PMID29216211
PMCPMC5720706
OpenAlexW2773829100

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.